Mon | Nov 29, 2021

Denmark prolongs suspension of AstraZeneca COVID-19 vaccine

Published:Thursday | March 25, 2021 | 9:42 AM
Tanja Erichsen, from the Danish Medicines Agency, speaks during a press briefing about the status of the AstraZeneca COVID-19 vaccine in Copenhagen, Thursday, March 25, 2021. Danish officials have decided to extend their suspension of the AstraZeneca COVID-19 vaccine by three weeks while they continue evaluating the vaccine’s potential link with blood clots. Denmark first paused the use of the AstraZeneca vaccine as a precautionary measure on March 11. (Mads Claus Rasmussen/Ritzau Scanpix via AP)

COPENHAGEN, Denmark (AP) — Danish officials decided Thursday to prolong their suspension of the AstraZeneca COVID-19 vaccine by three weeks while they continue evaluating a potential link with blood clots even though European Union regulators who looked into the issue have cleared the vaccine for use.

Denmark’s decision “was made on the basis of presumed side effects,” Tanja Erichsen of the Danish Medicines Agency said during a news conference.

”It can’t be ruled out that there is a connection between the vaccine and the very rare blood clot cases,” she said.

Denmark paused the use of the AstraZeneca vaccine as a precautionary measure on March 11 after reports that a 60-year-old woman died with blood clots in several parts of her body a week after she received the vaccine, according to health officials.

The death of a second person in Denmark who died after getting the AstraZeneca vaccine was reported. Danish health authorities said they have no evidence the vaccine was responsible for either death.

“I would like to emphasise that I am not talking about ordinary blood clots,” Erichsen said.

“It is not about blood clots in the arms, legs, and lungs.”

The pause will last at least until April 18. Norway and Sweden also suspended the AstraZeneca vaccine. Most European countries that had put the vaccine on hold resumed administering it after the European Medicines Agency said last week that it was safe.

Sweden’s Public Health Agency said Thursday it would resume giving AstraZeneca jabs to people over age 65 but it was recommending continuing to keep them on hold for other age groups while awaiting additional data.

Sweden suspended administering the AstraZeneca vaccine on March 16.

“The vaccine is very useful for the elderly as many become seriously ill with COVID-19 every day,” the Swedish agency’s director, Johan Carlson, said in a statement.

“At the same time, we haven’t seen a risk of these rare and serious side effects in the elderly. That is the reason why we are cancelling the break for people over the age of 65.”

Health officials in neighbouring Finland said late Wednesday that the country would resume using the AstraZeneca vaccine on Monday after a pause of over a week, but only would administer it to people over 65.

Follow The Gleaner on Twitter and Instagram @JamaicaGleaner and on Facebook @GleanerJamaica. Send us a message on WhatsApp at 1-876-499-0169 or email us at onlinefeedback@gleanerjm.com or editors@gleanerjm.com.